Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,289 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
SC 13D/A File 005-79364

RANDAL J KIRK SC13DA 1-20-2012 (ZIOPHARM ONCOLOGY, INC)

Filing date
25 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
25 Jan 2012
Reporting date
20 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2012
Reporting date
20 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-177793

FORM 424B5

Filing date
23 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-177793

FWP

Filing date
20 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
20 Jan 2012
Reporting date
19 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-177793

424B5

Filing date
19 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

CURRENT REPORT ON FORM 8-K

Filing date
11 Jan 2012
Reporting date
11 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

CURRENT REPORT ON FORM 8-K

Filing date
22 Dec 2011
Reporting date
22 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

CURRENT REPORT

Filing date
07 Dec 2011
Reporting date
07 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-177793

EFFECT filing

Filing date
16 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
15 Nov 2011
Reporting date
13 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-177793

FORM S-3

Filing date
07 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
03 Nov 2011
Reporting date
03 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .